August 6, 2008

Pfizer's respiratory and foot rot treatment product gets FDA approval

The FDA recently approved Pfizer's new EXCENEL RTU EZ (ceftiofur hydrochloride) Sterile Suspension to treat and control metritis, bovine and swine respiratory disease and foot rot.

EXCENEL RTU EZ supplies producers with the same efficacy as EXCENEL RTU in a tissue-friendly, low-volume dose. The new formulation, available in 100 mL vials, adds flexibility to management and treatment programmes due to the easier syringeability and ready-to-use packaging and flexible dosing.

In swine, EXCENEL RTU EZ has been approved for the treatment and control of the major causes of swine respiratory disease in growing and finishing pigs.

Intramuscular injections is made easier and effectively kills bacteria with no appreciable change in susceptibility in targeted swine pathogens.

EXCENEL RTU EZ is best-suited to the late finishing stage because it provides quick absorption in tissue and a short four-day pre-slaughter withdrawal time.

The treatment establishes therapeutic concentrations in one hour to treat a broad spectrum of pathogens that cause bacterial respiratory disease in swine; metritis, shipping fever, pneumonia and foot rot in dairy cows; and bovine respiratory disease in cattle.